France and Romania: Comparison of recommended vaccinations
Back to search
Export to spreadsheet
France Romania
    General recommendation
    Recommendation for specific groups only
    Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
BirthMonthsYears
23456111216-1825611131415171819242535456574≥ 75
Coronavirus disease (COVID-19)1
COVID-197
COVID-198
tuberculosis
BCG9
BCG10
diphtheria2
D
D
D
D
d
d11
d
d12
D
D
D
D
d
tetanus2
TT
TT
TT
TT
TT
TT11
TT
TT12
TT
TT
TT
TT
TT
pertussis
acP13
acP
acP
acP
acp
acp14
acP
acP
acP
acP
poliomyelitis
IPV
IPV
IPV
IPV
IPV
IPV11
IPV
IPV12
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib
Hib
Hib
Hib
Hib
Hib
hepatitis B
HepB15
HepB
HepB
HepB
HepB16
HepB17
HepB
HepB
HepB
pneumococcal disease3
PCV
PCV
PCV
PCV13+PPSV2318
PCV13
PCV13
PCV13
meningococcal disease4
MenB19
MenB - MenC20
MenB - MenC21
MenC22
measles5
MEAS23
MEAS
MEAS
MEAS24
MEAS25
MEAS
MEAS
mumps5
MUMPS
MUMPS
MUMPS24
MUMPS25
MUMPS
MUMPS
rubella5
RUBE
RUBE
RUBE24
RUBE26
RUBE
RUBE
human papillomavirus infection
HPV (F/M)27
HPV (F/M)28
HPV (F)29
influenza6
IIV4
IIV3
herpes zoster
ZOS30

Footnotes:

  1. https://www.has-sante.fr/jcms/p_3197104/fr/strategie-vaccinale-contre-le-sars-cov-2
  2. Risk group vaccination of dT for pregnant women
  3. Recommendations for specific at-risk groups: - High-risk older children (5 years and older) and adults should receive a mixed schedule comprising one dose of PCV13 followed by one dose of PPSV23 8 weeks later - Those same high risk individuals should receive a single booster dose of PPSV23 at least 5 years after the first dose of PPSV23
  4. MenB/MenC/MenACYW vaccination: Recommendations for specific at-risk groups apply - refer to the national immunisation policy document for further information (link provided below)
  5. contacts from outbreaks of measles, mumps, rubella and flue, regardless of age
  6. For risk groups established by the World Health Organization
  7. https://www.has-sante.fr/jcms/p_3178533/fr/vaccination-dans-le-cadre-de-la-covid-19
  8. https://vaccinare-covid.gov.ro/
  9. Only recommended for children at high-risk of tuberculosis. Please refer to original document for detailled information on risk-groups.
  10. Administration during the 2-7 days after delivery
  11. dTacp-IPV or dTT-IPV if last dTacp-IPV received in the previous 5 years
  12. dTT-IPV every 10 years from 65 years of age
  13. or 8 weeks of age
  14. For those who did not receive a dose of pertussis containing vaccine during the past 5 years, a booster with a quadrivalent vaccine (dTacp-IPV) is recommended at the time of the Td-IPV booster at 25 years. For those aged 25 years and above that did not receive a booster dose, catch-up with a dTacp-IPV vaccine can be proposed until 39 years of age. Recommendation to have an interval of 10 years in adults between a documented pertussis and pertussis re-vaccination.
  15. Babies born to a mother infected with hepatitis B will be offered a first dose at birth simultaneously with HB immunoglobulin, one month of age and 6 month of age. Four doses scheme (0-1-2-6 months) for premature <32 weeks or less than 2 kg. This intervention shall be evaluated at 9 month of age through HBs Ag and anti-HBs antibodies testing, preferably one to four month after the last vaccine dose.
  16. Three doses in a 0, 1, 6 month schedule. From 11 to 15 years, 2 doses in a 0, 6 schedule
  17. Within 24 hours after birth. In the event that the vaccine against Hepatitis B is not available, a different schedule applies for babies born of HBsAG positive mothers. More information available at: http://www.cnscbt.ro/index.php/calendarul-national-de-vaccinare
  18. For individuals from 5 years with increased risk of invasive pneumococcal disease. the scheme is based upon history of vaccination with PCV vaccines. if not previously vaccinated: PCV13 then PPSV23 (at least 8 weeks in between). If previous vaccination with PPSV23 >one year: PCV13 then PPSV23 (at least 5 years after initial PPSV23). If previously vaccinated with PCV13+PPSV23: further PPSV23 at least 5 years after the last dose.
  19. Vaccination introduced in 2022.
  20. Men B introduced in 2022. Not mandatory.
  21. Men B is not mandatory.
  22. 1 dose until 24 years
  23. Update 28 June 2013:For a full description of recommendations, please refer to: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=362. The vaccination from 9 months of age of children entering day care was suspended. Updated recommendations - Measles vaccination for infants under 12 months of age - travelling to countries of high measles endemicity or countries with no measles elimination programmes or in case of exposure to measles cases - One dose of monovalent measles vaccines for infants aged 6 to 8 months. Thereafter 2 doses of MMR as per national recommendations. - Trivalent vaccine can be used for infants aged 9 to 11 months. Thereafter 1 dose of MMR between 12 and 15 month. of MMR are recommended as per national recommendations. In case of exposure to measles cases, administration should occur within 72 hours after exposure to the index case.
  24. 2 doses of MMR one month appart if no previous vaccination ; 1 dose if only one dose previously
  25. Two MMR doses in total among individuals born from 1980
  26. Two MMR doses in total among individuals born from 1980. For rubella, one dose of MMR among unvaccinated woman.
  27. The extension of HPV vaccination to boys aged 11 to 14 with catch-up vaccination for those aged between 15 and 19. This recommendation is applicable since January 1, 2021.
  28. Girls and boy catch-up vaccination recommended. Three-dose schedule at 0, 1-2 and 6 months
  29. Girls-only vaccination recommended. Three-dose schedule.
  30. for further information, please consult: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=389